Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia M Mokhtar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the Egyptian National Cancer Institute|February 5, 2009
Review article composite lymphomaNadia M Mokhtar
Journal of the Egyptian National Cancer Institute|August 25, 2011
Clinicopathologic significance of molecular classification of breast cancer: relation to nottingham prognosis indexSherif Adly, Iman H Hewedi, Nadia M Mokhtar
Asian Pacific Journal of Cancer Prevention : APJCP|May 26, 2016
Association of Viral Infections with Risk of Human Lymphomas, EgyptDalia Y Kadry, Amira M Khorshed, Reham A Rashed, et al.
Journal of the Egyptian National Cancer Institute|October 23, 2009
Evaluation of bone marrow in 143 lymphomas: the relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validityTarek M N El Bolkainy, Wael S Abo Deif, Heba M Gouda, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 5, 2013
FHIT, EGFR, and MSH2: possible etiopathologic, prognostic, and predictive role in non-small cell lung carcinoma in Egyptian patientsSheren F Younes, Hayam A Aiad, Nancy Y Asaad, et al.
Journal of the Egyptian National Cancer Institute|November 12, 2013
Role of Ki67 in predicting resistance to adjuvant tamoxifen in postmenopausal breast cancer patientsHeba M Elzawahry, Magdy M Saber, Nadia M Mokhtar, et al.
BMC Cancer|January 28, 2009
Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancerHussein M Khaled, Abeer A Bahnassy, Amira A Raafat, et al.
Journal of the Egyptian National Cancer Institute|February 28, 2008
The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinomaAbeer A Bahnassy, Abdel Rahman N Zekri, Hanaa M Alam El-Din, et al.
Journal of the Egyptian National Cancer Institute|August 13, 2009
Evaluation of MIB-1 and p53 overexpression as risk factors in large cell non-Hodgkin lymphoma in adultsTarek N El-Bolkainy, Mohamed N El-Bolkainy, Hussein M Khaled, et al.
Journal of the Egyptian National Cancer Institute|December 15, 2005
Prognostic factors of Hodgkin's lymphoma and their impact on response to chemotherapy and survivalThoraya M Abdel Hamid, Heba M El Zawahry, Nabil A Khattab, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the Egyptian National Cancer Institute|February 5, 2009
Review article composite lymphomaNadia M Mokhtar
Journal of the Egyptian National Cancer Institute|August 25, 2011
Clinicopathologic significance of molecular classification of breast cancer: relation to nottingham prognosis indexSherif Adly, Iman H Hewedi, Nadia M Mokhtar
Asian Pacific Journal of Cancer Prevention : APJCP|May 26, 2016
Association of Viral Infections with Risk of Human Lymphomas, EgyptDalia Y Kadry, Amira M Khorshed, Reham A Rashed, et al.
Journal of the Egyptian National Cancer Institute|October 23, 2009
Evaluation of bone marrow in 143 lymphomas: the relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validityTarek M N El Bolkainy, Wael S Abo Deif, Heba M Gouda, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 5, 2013
FHIT, EGFR, and MSH2: possible etiopathologic, prognostic, and predictive role in non-small cell lung carcinoma in Egyptian patientsSheren F Younes, Hayam A Aiad, Nancy Y Asaad, et al.
Journal of the Egyptian National Cancer Institute|November 12, 2013
Role of Ki67 in predicting resistance to adjuvant tamoxifen in postmenopausal breast cancer patientsHeba M Elzawahry, Magdy M Saber, Nadia M Mokhtar, et al.
BMC Cancer|January 28, 2009
Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancerHussein M Khaled, Abeer A Bahnassy, Amira A Raafat, et al.
Journal of the Egyptian National Cancer Institute|February 28, 2008
The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinomaAbeer A Bahnassy, Abdel Rahman N Zekri, Hanaa M Alam El-Din, et al.
Journal of the Egyptian National Cancer Institute|August 13, 2009
Evaluation of MIB-1 and p53 overexpression as risk factors in large cell non-Hodgkin lymphoma in adultsTarek N El-Bolkainy, Mohamed N El-Bolkainy, Hussein M Khaled, et al.
Journal of the Egyptian National Cancer Institute|December 15, 2005
Prognostic factors of Hodgkin's lymphoma and their impact on response to chemotherapy and survivalThoraya M Abdel Hamid, Heba M El Zawahry, Nabil A Khattab, et al.
Pageof 2